-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pharmaceutical Network August 10, August 7, CDE official website shows that Zhejiang Xianyu Pharmaceutical's Shumore glucose sodium injection to copy 4 categories of submitted to the listing application to be accepted.
before this, Shu more glucose sodium injection has been Hunan Collum Pharmaceuticals, Yangzijiang Pharmaceuticals, Nanjing Zhengda Tianqing and other 12 enterprises submitted listing applications, and are copied 4 categories of declaration, after approval will be treated as if through the consistency evaluation.
-meter-net data show that in 2019, the global sales of Shugen sugar in Mershadong exceeded the $1 billion mark, while sales of Shugenic sugar at the end of China's public medical institutions increased by more than 800% year-on-year, with only one manufacturer in Mershadong.
recent global sales of Mersadong Su-sugar (in US$ million) data show that sodium sodium sodium sutrose injection is the world's first selective sagging antagonist used to reverse neuromuscular blockers, suitable for antagonic ammonium bromine or vicuco bromide-induced neuromuscular blockers.
-meter-net data show that in 2019, the global sales of Shuying glucan in Mershadong exceeded the $1 billion mark, while sales of Shu-more glucose in China's urban public hospitals, county-level public hospitals, urban community centers and township health centers (referred to as China's public medical institutions) increased by more than 800% year-on-year, with only one of the production enterprises in Mershadong.
before this, Shu more glucose sodium injection has been Hunan Collum Pharmaceuticals, Yangzijiang Pharmaceuticals, Nanjing Zhengda Tianqing and other 12 enterprises submitted listing applications, and are copied 4 categories of declaration, after approval will be treated as if through the consistency evaluation.
from the status of the start date, Hunan Collum Pharmaceuticals is the earliest.
Source: CDE Official Website, Mnet.com Database.
